HUP0202396A2 - Medicaments useful for treating fractures - Google Patents

Medicaments useful for treating fractures

Info

Publication number
HUP0202396A2
HUP0202396A2 HU0202396A HUP0202396A HUP0202396A2 HU P0202396 A2 HUP0202396 A2 HU P0202396A2 HU 0202396 A HU0202396 A HU 0202396A HU P0202396 A HUP0202396 A HU P0202396A HU P0202396 A2 HUP0202396 A2 HU P0202396A2
Authority
HU
Hungary
Prior art keywords
medicaments useful
treating fractures
fractures
treating
medicaments
Prior art date
Application number
HU0202396A
Other languages
Hungarian (hu)
Inventor
David G. Little
Original Assignee
The Royal Alexandra Hospital For Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Royal Alexandra Hospital For Children filed Critical The Royal Alexandra Hospital For Children
Publication of HUP0202396A2 publication Critical patent/HUP0202396A2/en
Publication of HUP0202396A3 publication Critical patent/HUP0202396A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány biszfoszfonátok csoportjából választott hatóanyagokravonatkozik, amelyek elősegítik a csontnövekedést és törött csontkezelésére alkalmasak. ÓThe invention relates to active substances selected from the group of bisphosphonates, which promote bone growth and are suitable for the treatment of broken bones. HE

HU0202396A 1999-08-19 2000-08-17 Medicaments useful for treating fractures HUP0202396A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ2325A AUPQ232599A0 (en) 1999-08-19 1999-08-19 Drug for treating fractures

Publications (2)

Publication Number Publication Date
HUP0202396A2 true HUP0202396A2 (en) 2002-11-28
HUP0202396A3 HUP0202396A3 (en) 2005-02-28

Family

ID=3816500

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202396A HUP0202396A3 (en) 1999-08-19 2000-08-17 Medicaments useful for treating fractures

Country Status (16)

Country Link
EP (1) EP1214079A4 (en)
JP (1) JP2003507426A (en)
KR (1) KR20020027562A (en)
CN (1) CN100345548C (en)
AU (1) AUPQ232599A0 (en)
BR (1) BR0013416A (en)
CA (1) CA2381302A1 (en)
HK (1) HK1048441B (en)
HU (1) HUP0202396A3 (en)
IL (1) IL148166A0 (en)
NO (1) NO20020784L (en)
NZ (1) NZ517538A (en)
PL (1) PL353485A1 (en)
SK (1) SK2382002A3 (en)
WO (1) WO2001013922A1 (en)
ZA (1) ZA200202160B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK9862003A3 (en) * 2001-02-06 2004-02-03 Royal Alexandra Hosp Children A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
NZ528659A (en) * 2001-04-03 2005-02-25 Royal Alexandra Hosp Children A drug for use in bone grafting
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone
ES2561463T3 (en) * 2003-08-21 2016-02-26 Addbio Ab Implant device coated with bisphosphonate and method for it
AU2004273672A1 (en) * 2003-09-19 2005-03-31 Wisconsin Alumni Research Foundation Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
ITMI20040218A1 (en) * 2004-02-10 2004-05-10 Abiogen Pharma Spa USE OF SODIUM NERHYDRONATE TO PROMOTE BONE NEOFORMATION
ITMI20040641A1 (en) * 2004-03-31 2004-06-30 Tb Technology S R L BIFUNCTIONAL BIOADHESIVE COMPOSITIONS FOR ORAL IMPLANTOLOGY
AR048742A1 (en) * 2004-12-22 2006-05-24 Gador Sa INTRA-ORAL MEDICINES APPLICATION SYSTEM
KR101315925B1 (en) * 2005-10-27 2013-10-08 토멘 메디칼 아게 Dental implant and production method for said implant
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8107560A (en) * 1981-11-19 1983-07-05 Luiz Romariz Duarte ULTRASONIC STIMULATION OF BONE FRACTURE CONSOLIDATION
JPH07502507A (en) * 1991-12-17 1995-03-16 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド Method for treating osteoporosis using bisphosphonates and parathyroid hormone
AU670337B2 (en) * 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
JPH11506750A (en) * 1995-06-06 1999-06-15 メルク エンド カンパニー インコーポレーテッド Bisphosphonate therapy for bone defects associated with rheumatoid arthritis
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
GB9613722D0 (en) * 1996-06-28 1996-08-28 Univ Liverpool Chemical compounds

Also Published As

Publication number Publication date
NZ517538A (en) 2003-07-25
KR20020027562A (en) 2002-04-13
CN1370071A (en) 2002-09-18
HUP0202396A3 (en) 2005-02-28
CA2381302A1 (en) 2001-03-01
HK1048441B (en) 2008-02-22
IL148166A0 (en) 2002-09-12
NO20020784D0 (en) 2002-02-18
EP1214079A4 (en) 2004-03-24
WO2001013922A1 (en) 2001-03-01
CN100345548C (en) 2007-10-31
PL353485A1 (en) 2003-11-17
NO20020784L (en) 2002-02-18
JP2003507426A (en) 2003-02-25
EP1214079A1 (en) 2002-06-19
AUPQ232599A0 (en) 1999-09-09
SK2382002A3 (en) 2002-09-10
ZA200202160B (en) 2003-08-27
HK1048441A1 (en) 2003-04-04
BR0013416A (en) 2002-04-30

Similar Documents

Publication Publication Date Title
BR0016058A (en) Phosphonate Compounds
ZA964816B (en) Implant for the surgical treatment of a vertebral isthmus fracture.
DE60328476D1 (en) MEDICAL BALLOON SYSTEM FOR THE TREATMENT OF ADIPOSITAS
DE60228096D1 (en) Gewebtes orthopädisches implantat
ATE329540T1 (en) BONE PLATE FOR FIXATION OF PROXIMAL HUMERUS FRACTURES
AU2001258138A1 (en) Bone plate for the fixation of fractures of the proximal humerus
DE69811933T2 (en) SPINAL IMPLANT
FI952701A0 (en) Process for the treatment of a metallic surgical implant
DE60019473D1 (en) (S, S) reboxetine for the treatment of peripheral neuropathies
ATE395871T1 (en) INTEGRAL NAIL FOR THE TREATMENT OF PROXIMAL FEMUR Fractures
EE04221B1 (en) Use of estrogen in the manufacture of a medicament for the treatment of physical conditions in postmenopausal individuals
BR0100558A (en) Compositions and methods for treating osteoporosis
DE60028863D1 (en) Electrosurgical handpiece for the treatment of tissue
HUP0303013A2 (en) A drug for treatment of osteonecrosis and for the management of patients at risk developing osteonecrosis
BR9708114A (en) Xanthone analogues for the treatment of infectious diseases.
EA200702212A1 (en) METHOD OF TREATMENT OR PREVENTION OF BONE DESTRUCTION OR OSTEOPOROSIS
ATE232874T1 (en) PROSTAGLANDIN CONJUGATES FOR THE TREATMENT OF BONE DISEASES
DE60027209D1 (en) MEDICAMENT CONTAINS HYDROXYAPATITE FOR THE TREATMENT OF BONE WEBBLE DISEASES
HUP0202396A2 (en) Medicaments useful for treating fractures
ATE443527T1 (en) 5-CNAC FOR ORAL ADMINISTRATION OF PARATHORMONE FRAGMENTS
DE60223707D1 (en) CALCIUM-L-THREONATE FOR THE TREATMENT OF BONE FRACTURES
NO20012106D0 (en) Drug for the treatment of bone pathobolism
ATE253936T1 (en) GLUTATHIONE REDUCTASE FOR THE TREATMENT AND PROPHYLAXIS OF AIDS
UA28497A (en) Method for treatment of unstable fracture of radial bones distal end
DE29903763U1 (en) Cerclage tape for the treatment of broken bones

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees